Clinical pharmacology of mirtazapine: revisited.
Davis
J
J
Barkin
R L
RL
D000380:Agranulocytosis / Q000139:chemically induced; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000494:pharmacology*; D001007:Anxiety / Q000523:psychology; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D000078785:Mirtazapine; D011595:Psychomotor Agitation / Q000523:psychology; D020018:Sexual Dysfunctions, Psychological / Q000523:psychology; D007319:Sleep Initiation and Maintenance Disorders / Q000523:psychology
D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine